---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-052635"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:19:17.452657+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aditxt appoints Evofem CEO Saundra Pelletier to board; officer loans $70K

## Summary
- Board appoints Saundra Pelletier (CEO of Evofem) as director, effective June 5, 2025.
- Chief Innovation Officer Shahrokh Shabahang loans $70,000 at 7.5%, due Dec 5, 2025.
- Weekly update: Adimune targets Q4 2025 regulatory submission for ADI-100 autoimmune therapy.
- Evofem generated $20M net revenue in 2024; CEO cites capital dependency for growth.
- Pending Evofem merger extended to Sept 30, 2025; capital needed for milestones.

## SEC filing metadata
- accession: 0001213900-25-052635
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/0001213900-25-052635-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/ea0245171-8k_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-052635
- JSON: https://secwatch.observer/filing/0001213900-25-052635.json
- Plain text: https://secwatch.observer/filing/0001213900-25-052635.txt

## Key facts
- Executive change
  Saundra Pelletier was appointed as director at Aditxt, Inc..
  - Action: appointed
  - Role: director
  source text: On June 5, 2025, the Board of Directors (the “ Board ”) of the Company, with the recommendation of the Nominating and Corporate Governance Committee, appointed Ms. Saundra Pelletier as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390025052635/0001213900-25-052635-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.